The Exchange has received the disclosure under Regulation 18(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sunil Shah & Others

SU IL CHI UBHAI SHAH Vidyabhavan, 22/39 New JaganathPlot, Dr. Yagnik Road, Rajkot, Gujarat BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai -400 001, Maharashtra, India. Parmax Pharma Limited Plot No. 20, Survey No. 52, Rajkot-Gondal National Highway No. 27, Hadamtala, Tal. Kotda Sangani, Rajkot, Gujarat, 360311 Scrip ID: PARMAX | Scrip Code: 540359 Dear Sir/Madam, Sub: Disclosure under Regulations 18(6) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, as amended (“SEBI (SAST) Regulations”). This is to inform you that, Dhiren Chandulal Shah (“Acquirer 1”) and Sunil Chinubhai Shah (“Acquirer 2”), Dhairya Dhiren Shah (“PAC 1”), Hiren Pravin Doshi (“PAC 2”), Sheetal Hiren Doshi (“PAC 3”), Nirmal Sunilbhai Shah (“PAC 4”), Vijaykumar Natvarlal Shiyani (“PAC 6”) and Kamlesh Natvarlal Shiyani (“PAC 7”), in terms of the SEBI (SAST) Regulations, have acquired 11,52,450 equity shares of face value of Rs. 10.00 each of Parmax Pharma Limited ("Target Company) on August 13, 2026 pursuant to the Share Purchase Agreement dated June 08, 2026. This disclosure is being submitted in compliance with Regulation 18(6) of the SEBI (Substantial Acquisition ofShares and Takeovers) Regulations, 2011. You are requested to kindly take the same on record and acknowledge receipt of this disclosure. Thanking you. Yours faithfully, For and on behalf of Accqquirer 1 and Acquirer 2 Sunil Chinubhai Shah Acquirer 2 Copy to: Bhakti Aghera Company Secretary Parmax Pharma Limited Plot No. 20, Survey No. 52, Rajkot-Gondal National Highway No. 27, Hadamtala, Tal. Kotda Sangani, Rajkot, Gujarat, 360311 SU IL CHI UBHAI SHAH Vidyabhavan, 22/39 New Jaganath Plot, Dr. Yagnik Road, Rajkot, Gujarat Format for Disclosure by acquirer for shares/ voting rights acquired during the offer period under Regulation 18 (6) in terms of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 (i) !ame of the Target Parmax Pharma Limited Company (TC) (ii) !ame of the acquirers/ PAC Dhiren Chandulal Shah (“Acquirer 1”) and Sunil Chinubhai Shah (“Acquirer 2”) Dhairya Dhiren Shah (“PAC 1”), Hiren Pravin Doshi (“PAC 2”), Sheetal Hiren Doshi (“PAC 3”), Nirmal Sunilbhai Shah (“PAC 4”), Rupa Sunil Shah (“PAC 5”), Vijaykumar Natvarlal Shiyani (“PAC 6”), Kamlesh Natvarlal Shiyani (“PAC 7”), Abhay Chinubhai Shah (“PAC 8”), Umang Alkesh Gosalia (“PAC 9”) and Meena Alkesh Gosalia (“PAC 10”) (iii) !ame of the persons/ Dhiren Chandulal Shah (“Acquirer 1”) and Sunil Chinubhai entities who acquired shares Shah (“Acquirer 2”), Dhairya Dhiren Shah (“PAC 1”), Hiren in the TC Pravin Doshi (“PAC 2”), Sheetal Hiren Doshi (“PAC 3”), Nirmal Sunilbhai Shah (“PAC 4”), Vijaykumar Natvarlal Shiyani (“PAC 6”) and Kamlesh Natvarlal Shiyani (“PAC 7”) (iv) Whether disclosure about Yes, Dhiren Chandulal Shah (“Acquirer 1”) and Sunil the persons / entities stated Chinubhai Shah (“Acquirer 2”), Dhairya Dhiren Shah (“PAC at (iii) was given in the 1”), Hiren Pravin Doshi (“PAC 2”), Sheetal Hiren Doshi detailed public (“PAC 3”), Nirmal Sunilbhai Shah (“PAC 4”), Vijaykumar announcement as either Natvarlal Shiyani (“PAC 6”) and Kamlesh Natvarlal Shiyani Acquirer or Persons acting (“PAC 7”), have been disclosed as Acquirer 1, Acquirer 2, in concert with Acquirer. PAC 1, PAC 2, PAC 3, PAC 4, PAC 6 and PAC 7 in the public (Yes/!o) announcement dated June 08, 2026, the detailed public statement published on June 15, 2026, the Draft Letter of If no, provide Offer dated June 22, 2026 and the Letter of Offer dated July (a) Reasons for non- 21, 2026. disclosure (b) Relationship of the entity with the Acquirer/ Person Shareholding of person !umber from who acquired the shares of Shares Date of Mode of whom Purchase (% w.r.t. total share / Voting Acquisition Acquisition Shares / Price per Capital/ voting capital of Rights Voting Share Target Company) Acquired Rights Before After Acquired acquisition Acquisition** Off market Alkesh Acquirer 1: acquisition Mahasukhlal 4,67,238 Acquirer of equity Gopani Acquirer (12.49% of 1: 13/08/2026 shares (Seller 1), 35.00 1: the the total 4,67,238 pursuant to Vipul Nil number of Share Mahasukhlal equity shares Purchase Gopani of TC) SU IL CHI UBHAI SHAH Vidyabhavan, 22/39 New Jaganath Plot, Dr. Yagnik Road, Rajkot, Gujarat Agreement (Seller 2) Acquirer 2: dated June and Pravina 71,077 Acquirer 08, 2026 * Mahasukh Acquirer (1.90% of the 2: Gopani 2: the total 71,077 (Seller 3) Nil number of equity shares of TC) PAC 1: 93,448 (2.50% of the PAC 1: PAC 1: the total 93,448 Nil number of equity shares of TC) PAC 2: 1,68,206 (4.50% of the PAC 2: PAC 2: the total 1,68,206 Nil number of equity shares of TC) PAC 3: 18,690 (0.50% of the PAC 3: PAC 3: the total 18,690 Nil number of equity shares of TC) PAC 4: 1,24,597 (3.33% of the PAC 4: PAC 4: the total 92,097 32,500 number of equity shares of TC) PAC 6: 1,24,597 (3.33% of the PAC 6: PAC 6: the total 1,24,597 Nil number of equity shares of TC) PAC 7: 1,24,597 (3.33% of the PAC 7: PAC 7: the total 1,17,097 7,500 number of equity shares of TC) 10,17,714 Total shareholding of acquirers and PACs before the acquisition (27.20% of the the total (number as well as % of total share capital of TC) number of equity shares of SU IL CHI UBHAI SHAH Vidyabhavan, 22/39 New JaganathPlot, Dr. Yagnik Road, Rajkot, Gujarat 21,70,164 TOTAL shareholding of acquirers and PACs after the (58.01% of the the total acquisition number of equity shares of (!umber as well as % of total share capital of TC) *Pursuant to the share purchase agreement dated June 08, 2026 (“SPA”) executed between the Acquirer 1, Acquirer 2, PAC 1, PAC 2, PAC 3, PAC 4, PAC 6, PAC 7 and the Sellers, the Acquirer 1, Acquirer 2, PAC 1, PAC 2, PAC 3, PAC 4, PAC 6 and PAC 7 have acquired an aggregate of 11,52,450 equity shares of the TC from the Sellers on August 13, 2026 in accordance with the terms and conditions set out under the SPA, and other applicable laws. **Acquirer 1, Acquirer 2, PAC 1, PAC 2, PAC 3, PAC 4, PAC 6 and PAC 7havepaid the consideration amount for acquisition of the shares. Further, the said shares are yet to be credited to their respective demat accounts. I hereby declare that the information provided in the instant report is true and nothing has been concealed therefrom. For and on behalf of Accqquirer 1 and Acquirer 2 Sunil Chinubhai Shah Acquirer 2 Date:13/08/2026 Place:Rajkot